As a leading innovator in the emerging field of synthetic biology, Jay Keasling has helped revolutionize its applications in far-reaching ways that have impacted the fields of medicine, chemistry and clean energy.
Synthetic biology is a relatively new field that combines molecular biology, chemistry and genetic engineering, and Dr. Keasling, arguably the face of this new discipline, has engineered microbial "factories" to produce chemicals ranging from medicines to biofuels in cheaper, more environmentally benign ways.
Perhaps his most significant application has been using these engineered biological factories to produce an otherwise prohibitively expensive drug artemisinin, a plant-derived, anti-malarial drug that is saving lives in the developing world. Working out of the University of California, Berkeley and the Lawrence Berkeley National Laboratory, Dr. Keasling applied his pioneering techniques to develop an alternative, low-cost way to produce this critical medicine.
It was important to Dr. Keasling that the artemisinin would be affordable to children and adults for whom it was intended. To do so, he was able to create a unique private/public partnership to license the patents royalty-free in developing countries so the medicine would be produced at large scales, and provided at cost, ensuring delivery where it is needed most.
Using similar techniques, Dr. Keasling most recently has created tank-ready, non-petroleum-based biofuels and chemicals from agricultural feedstocks such as cellulosic biomass, a less energy-intensive and controversial method than using corn.
Having grown up working on his father's farm in Nebraska, Jay Keasling's agricultural roots remain at the forefront of his work today, even as it relates to biofuels. His research in these disciplines, and the deep humanitarian compassion that he is noted for, is proof that invention and technology can lead the way to a more sustainable future.
Note: This profile is excerpted from the commemorative brochure published at the time of the awards' presentation.
UPDATES SINCE RECEIVING THE HEINZ AWARD
October 2015 - Jay Keasling wins the third annual Eric and Sheila Samson Prime Minister’s Prize for Innovation in Alternative Fuels for Transportation, a $1 million Israeli award to the world’s top innovators in the alternative transportation sector. - The Jerusalem Post
September 2014 - Jay Keasling receives the 2014 Economist Innovation Award in BioScience for his development of "synthetic artemisinin used to treat malaria." - The Economist Innovation Awards